{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:55:46Z","timestamp":1787241346728,"version":"build-2736575974"},"reference-count":20,"publisher":"The Fukushima Society of Medical Science","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FJMS","Fukushima J. Med. Sci."],"published-print":{"date-parts":[[2017]]},"DOI":"10.5387\/fms.2017-07","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T17:11:09Z","timestamp":1510679469000},"page":"165-171","source":"Crossref","is-referenced-by-count":8,"title":["Two cases of liver cirrhosis treated with lusutrombopag before partial splenic embolization"],"prefix":"10.5387","volume":"63","author":[{"given":"Masashi","family":"Fujita","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumichi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Okai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yoshida H, Mamada Y, Taniai N, Tajiri T. Partial splenic embolization. Hepatology Res, <b>38<\/b>:225-233, 2008.","DOI":"10.1111\/j.1872-034X.2007.00302.x"},{"key":"2","unstructured":"2. Bissonnette J, Valla D, Rautou PE. Managing periprocedural thrombocytopenia in cirrhosis: Aiming for a safety window. J Hepatol, <b>61<\/b>: 1199-1201, 2014."},{"key":"3","doi-asserted-by":"crossref","unstructured":"4. Katsube T, Ishibashi T, Kano T, Wajima T. Population pharmacokinetic and pharmacodynamic modeling of lusutrombopag, a newly developed oral thrombopoietin receptor agonist, in healthy subjects. Clin Phamacokinet, <b>55<\/b>:1423-1433, 2016.","DOI":"10.1007\/s40262-016-0411-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5. Shimizu H, Takatsuka K, Yoshida A, Yoshimatsu E, Matsui K, Iwabuchi S. Partial splenic embolization reverses insulin resistance in patients with liver cirrhosis. Intern Med, <b>48<\/b>:747-751, 2009.","DOI":"10.2169\/internalmedicine.48.1649"},{"key":"5","doi-asserted-by":"crossref","unstructured":"7. Saito H, Maruyama I, Shimazaki S, <i>et al<\/i>. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost,<b> 5<\/b>: 31-41, 2007.","DOI":"10.1111\/j.1538-7836.2006.02267.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"8. Spigos DG, Jonasson O, Mozes M, Capek V. Partial splenic embolization in the treatment of hypersplenism. AJR Am J Roentgenol, <b>132<\/b>:777-782, 1979.","DOI":"10.2214\/ajr.132.5.777"},{"key":"7","doi-asserted-by":"crossref","unstructured":"9. Sangro B, Bilbao I, Herrero I, <i>et al<\/i>. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology, <b>18<\/b>:309-314, 1993.","DOI":"10.1016\/0270-9139(93)90013-D"},{"key":"8","doi-asserted-by":"crossref","unstructured":"11. Hidaka H, Kokubu S, Nakazawa T, <i>et al<\/i>. Therapeutic benefits of partial splenic embolization for thrombocytopenia in hepatocellular carcinoma patients treated with radiofrequency ablation. Hepatol Res, <b>39<\/b>:772-778, 2009.","DOI":"10.1111\/j.1872-034X.2009.00508.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"12. Miyake Y, Ando M, Kaji E, Toyokawa T, Nakatsu M, Hirohata M. Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Hepatol Res, <b>38<\/b>:980-986, 2008.","DOI":"10.1111\/j.1872-034X.2008.00357.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"13. McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion, <b>31<\/b>:164-171, 1991.","DOI":"10.1046\/j.1537-2995.1991.31291142949.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"14. Seeff LB, Everson GT, Morgan TR, <i>et al<\/i>. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol, <b>8<\/b>: 887-883, 2010.","DOI":"10.1016\/j.cgh.2010.03.025"},{"key":"12","unstructured":"17. Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion of plasma and platelets. Blood Transfus, <b>7<\/b>:132-150, 2009."},{"key":"13","doi-asserted-by":"crossref","unstructured":"18. Poordad F. Thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther, <b>26<\/b>:5-11, 2007.","DOI":"10.1111\/j.1365-2036.2007.03510.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"19. Nurden AT, Viallard JF, Nurden P. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura. Lancet, <b>373<\/b>:1562-1569, 2009.","DOI":"10.1016\/S0140-6736(09)60255-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"20. Sakamaki A, Watanabe T, Abe S, <i>et al<\/i>. Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient. Clin J Gastroenterol, <b>10<\/b>: 261-264, 2017.","DOI":"10.1007\/s12328-017-0735-2"},{"key":"16","unstructured":"21. Kuter DJ, Begley CG. Recombinant human thrombopoietin:basic biology and evaluation of clinical studies. Blood, <b>100<\/b>:3457-3469, 2002."},{"key":"17","doi-asserted-by":"crossref","unstructured":"24. Wada H, Thachil J, Di Nisho M. Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines. J Thromb Haemost, <b>11<\/b>:761-767, 2013.","DOI":"10.1111\/jth.12155"},{"key":"18","unstructured":"25. Asakura H. Classifying types of disseminated intravascular coagulation:clinical and animal models. J Intensive Care, <b>2<\/b>:20, 2014."},{"key":"19","doi-asserted-by":"crossref","unstructured":"26. Afdhal N, Giannini E, Tayyab G, <i>et al<\/i>. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med, <b>367<\/b>:716-724, 2012.","DOI":"10.1056\/NEJMoa1110709"},{"key":"20","doi-asserted-by":"crossref","unstructured":"27. Kuter DJ, Mufti GJ, Bain BJ, Hasserjian RP, Davis W, Rutstein M. Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. Blood, <b>114<\/b>: 3748-3756, 2009.","DOI":"10.1182\/blood-2009-05-224766"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/63\/3\/63_2017-07\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T00:31:38Z","timestamp":1570321898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/63\/3\/63_2017-07\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.2017-07","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}